{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T15:09:19Z","timestamp":1789571359026,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,4,15]],"date-time":"2015-04-15T00:00:00Z","timestamp":1429056000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s00277-015-2361-8","type":"journal-article","created":{"date-parts":[[2015,4,13]],"date-time":"2015-04-13T23:31:15Z","timestamp":1428967875000},"page":"1389-1400","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["The prognostic nutritional index predicts survival for patients with extranodal natural killer\/T cell lymphoma, nasal type"],"prefix":"10.1007","volume":"94","author":[{"given":"Kai-Lin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-Kui","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Rong","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Qi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Qiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Jun","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Qing","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,15]]},"reference":[{"issue":"5","key":"2361_CR1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1155\/2010\/474692","volume":"29","author":"H-Q Guo","year":"2010","unstructured":"Guo H-Q, Huang G-L, Guo C-C, Pu X-X, Lin T-Y (2010) Diagnostic and prognostic value of circulating miR-221 for extranodal natural killer\/T-cell lymphoma. Dis Markers 29(5):251\u2013258","journal-title":"Dis Markers"},{"issue":"1","key":"2361_CR2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.oraloncology.2006.03.011","volume":"43","author":"DA Al-Hakeem","year":"2007","unstructured":"Al-Hakeem DA, Fedele S, Carlos R, Porter S (2007) Extranodal NK\/T-cell lymphoma, nasal type. Oral Oncol 43(1):4\u201314","journal-title":"Oral Oncol"},{"issue":"1","key":"2361_CR3","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1182\/blood-2003-05-1401","volume":"103","author":"CS Chim","year":"2004","unstructured":"Chim CS, Ma SY, Au WY, Choy C, Lie AK, Liang R, Yau CC, Kwong YL (2004) Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index. Blood 103(1):216\u2013221. doi: 10.1182\/blood-2003-05-1401","journal-title":"Blood"},{"issue":"1","key":"2361_CR4","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0360-3016(02)02916-4","volume":"54","author":"MM Cheung","year":"2002","unstructured":"Cheung MM, Chan JK, Lau WH, Ngan RK, Foo WW (2002) Early stage nasal NK\/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality. Int J Radiat Oncol Biol Phys 54(1):182\u2013190","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"17","key":"2361_CR5","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1182\/blood-2008-10-185256","volume":"113","author":"WY Au","year":"2009","unstructured":"Au WY, Weisenburger DD, Intragumtornchai T, Nakamura S, Kim WS, Sng I, Vose J, Armitage JO, Liang R (2009) Clinical differences between nasal and extranasal natural killer\/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project. Blood 113(17):3931\u20133937. doi: 10.1182\/blood-2008-10-185256","journal-title":"Blood"},{"issue":"4","key":"2361_CR6","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/annonc\/mdl466","volume":"18","author":"J Rodriguez","year":"2007","unstructured":"Rodriguez J, Conde E, Gutierrez A, Arranz R, Leon A, Marin J, Bendandi M, Albo C, Caballero MD (2007) The results of consolidation with autologous stem-cell transplantation in patients with peripheral T-cell lymphoma (PTCL) in first complete remission: the Spanish Lymphoma and Autologous Transplantation Group experience. Ann Oncol 18(4):652\u2013657. doi: 10.1093\/annonc\/mdl466","journal-title":"Ann Oncol"},{"issue":"4","key":"2361_CR7","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1080\/10428190601123989","volume":"48","author":"BB Park","year":"2007","unstructured":"Park BB, Ryoo BY, Lee JH, Kwon HC, Yang SH, Kang HJ, Kim HJ, Oh SY, Ko YH, Huh JR, Lee SS, Nam EM, Park KW, Kim JH, Kang JH, Bang SM, Park S, Kim K, Park K, Suh C, Kim WS (2007) Clinical features and treatment outcomes of angioimmunoblastic T-cell lymphoma. Leuk Lymphoma 48(4):716\u2013722. doi: 10.1080\/10428190601123989","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"2361_CR8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/annonc\/mdq314","volume":"22","author":"JJ Huang","year":"2011","unstructured":"Huang JJ, Jiang WQ, Lin TY, Huang Y, Xu RH, Huang HQ, Li ZM (2011) Absolute lymphocyte count is a novel prognostic indicator in extranodal natural killer\/T-cell lymphoma, nasal type. Ann Oncol 22(1):149\u2013155. doi: 10.1093\/annonc\/mdq314","journal-title":"Ann Oncol"},{"issue":"8","key":"2361_CR9","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s00277-014-2031-2","volume":"93","author":"S Dalia","year":"2014","unstructured":"Dalia S, Chavez J, Little B, Bello C, Fisher K, Lee JH, Chervenick P, Sokol L, Sotomayor E, Shah B (2014) Serum albumin retains independent prognostic significance in diffuse large B-cell lymphoma in the post-rituximab era. Ann Hematol 93(8):1305\u20131312. doi: 10.1007\/s00277-014-2031-2","journal-title":"Ann Hematol"},{"issue":"12","key":"2361_CR10","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1182\/blood-2005-11-4659","volume":"107","author":"L Arcaini","year":"2006","unstructured":"Arcaini L, Lazzarino M, Colombo N, Burcheri S, Boveri E, Paulli M, Morra E, Gambacorta M, Cortelazzo S, Tucci A, Ungari M, Ambrosetti A, Menestrina F, Orsucci L, Novero D, Pulsoni A, Frezzato M, Gaidano G, Vallisa D, Minardi V, Tripodo C, Callea V, Baldini L, Merli F, Federico M, Franco V, Iannitto E (2006) Splenic marginal zone lymphoma: a prognostic model for clinical use. Blood 107(12):4643\u20134649. doi: 10.1182\/blood-2005-11-4659","journal-title":"Blood"},{"issue":"21","key":"2361_CR11","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199811193392104","volume":"339","author":"D Hasenclever","year":"1998","unstructured":"Hasenclever D, Diehl V (1998) A prognostic score for advanced Hodgkin\u2019s disease. International Prognostic Factors Project on Advanced Hodgkin\u2019s Disease. N Engl J Med 339(21):1506\u20131514. doi: 10.1056\/nejm199811193392104","journal-title":"N Engl J Med"},{"key":"2361_CR12","author":"K Sun","year":"2014","unstructured":"Sun K, Chen S, Xu J, Li G, He Y (2014) The prognostic significance of the prognostic nutritional index in cancer: a systematic review and meta-analysis. J Cancer Res Clin Oncol. doi: 10.1007\/s00432-014-1714-3","journal-title":"J Cancer Res Clin Oncol"},{"issue":"8","key":"2361_CR13","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1038\/bjc.2012.92","volume":"106","author":"DJ Pinato","year":"2012","unstructured":"Pinato DJ, North BV, Sharma R (2012) A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI). Br J Cancer 106(8):1439\u20131445. doi: 10.1038\/bjc.2012.92","journal-title":"Br J Cancer"},{"issue":"6","key":"2361_CR14","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/bjc.2012.354","volume":"107","author":"A Kinoshita","year":"2012","unstructured":"Kinoshita A, Onoda H, Imai N, Iwaku A, Oishi M, Fushiya N, Koike K, Nishino H, Tajiri H (2012) Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma. Br J Cancer 107(6):988\u2013993. doi: 10.1038\/bjc.2012.354","journal-title":"Br J Cancer"},{"issue":"4","key":"2361_CR15","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1200\/JCO.2005.04.1384","volume":"24","author":"J Lee","year":"2006","unstructured":"Lee J, Suh C, Park YH, Ko YH, Bang SM, Lee JH, Lee DH, Huh J, Oh SY, Kwon HC, Kim HJ, Lee SI, Kim JH, Park J, Oh SJ, Kim K, Jung C, Park K, Kim WS (2006) Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study. J Clin Oncol 24(4):612\u2013618. doi: 10.1200\/jco.2005.04.1384","journal-title":"J Clin Oncol"},{"issue":"2","key":"2361_CR16","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/bjc.2012.566","volume":"108","author":"Q Cai","year":"2013","unstructured":"Cai Q, Luo X, Liang Y, Rao H, Fang X, Jiang W, Lin T, Lin T, Huang H (2013) Fasting blood glucose is a novel prognostic indicator for extranodal natural killer\/T-cell lymphoma, nasal type. Br J Cancer 108(2):380\u2013386. doi: 10.1038\/bjc.2012.566","journal-title":"Br J Cancer"},{"issue":"10","key":"2361_CR17","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.ejca.2005.03.010","volume":"41","author":"J Lee","year":"2005","unstructured":"Lee J, Park YH, Kim WS, Lee SS, Ryoo BY, Yang SH, Park KW, Kang JH, Park JO, Lee SH, Kim K, Jung CW, Park YS, Im YH, Kang WK, Lee MH, Ko YH, Ahn YC, Park K (2005) Extranodal nasal type NK\/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy. Eur J Cancer 41(10):1402\u20131408. doi: 10.1016\/j.ejca.2005.03.010","journal-title":"Eur J Cancer"},{"issue":"12","key":"2361_CR18","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1111\/j.1349-7006.2009.01319.x","volume":"100","author":"TM Kim","year":"2009","unstructured":"Kim TM, Heo DS (2009) Extranodal NK\/T-cell lymphoma, nasal type: new staging system and treatment strategies. Cancer Sci 100(12):2242\u20132248","journal-title":"Cancer Sci"},{"issue":"17","key":"2361_CR19","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1016\/j.ejca.2011.03.028","volume":"47","author":"MJ Proctor","year":"2011","unstructured":"Proctor MJ, Morrison DS, Talwar D, Balmer SM, Fletcher CD, O'Reilly DS, Foulis AK, Horgan PG, McMillan DC (2011) A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study. Eur J Cancer 47(17):2633\u20132641. doi: 10.1016\/j.ejca.2011.03.028","journal-title":"Eur J Cancer"},{"issue":"4","key":"2361_CR20","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","volume":"17","author":"BD Cheson","year":"1999","unstructured":"Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM, Lister TA, Vose J, Grillo-Lopez A, Hagenbeek A, Cabanillas F, Klippensten D, Hiddemann W, Castellino R, Harris NL, Armitage JO, Carter W, Hoppe R, Canellos GP (1999) Report of an international workshop to standardize response criteria for non-Hodgkin\u2019s lymphomas. NCI Sponsored International Working Group. J Clin Oncol 17(4):1244","journal-title":"J Clin Oncol"},{"issue":"4","key":"2361_CR21","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1023\/A:1008332713631","volume":"11","author":"AJ Grillo-Lopez","year":"2000","unstructured":"Grillo-Lopez AJ, Cheson BD, Horning SJ, Peterson BA, Carter WD, Varns CL, Klippenstein DL, Shen CD (2000) Response criteria for NHL: importance of \u2018normal\u2019 lymph node size and correlations with response rates. Ann Oncol 11(4):399\u2013408","journal-title":"Ann Oncol"},{"issue":"1","key":"2361_CR22","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0002-9610(80)90246-9","volume":"139","author":"GP Buzby","year":"1980","unstructured":"Buzby GP, Mullen JL, Matthews DC, Hobbs CL, Rosato EF (1980) Prognostic Nutritional Index in gastrointestinal surgery. Am J Surg 139(1):160\u2013167","journal-title":"Am J Surg"},{"issue":"1","key":"2361_CR23","first-page":"31","volume":"26","author":"A Aviles","year":"1995","unstructured":"Aviles A, Yanez J, Lopez T, Garcia EL, Guzman R, Diaz-Maqueo JC (1995) Malnutrition as an adverse prognostic factor in patients with diffuse large cell lymphoma. Arch Med Res 26(1):31\u201334","journal-title":"Arch Med Res"},{"issue":"3","key":"2361_CR24","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/MCO.0b013e32832a7902","volume":"12","author":"DC McMillan","year":"2009","unstructured":"McMillan DC (2009) Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care 12(3):223\u2013226. doi: 10.1097\/MCO.0b013e32832a7902","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"13","key":"2361_CR25","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1158\/0008-5472.CAN-08-3845","volume":"69","author":"I Ray-Coquard","year":"2009","unstructured":"Ray-Coquard I, Cropet C, Van Glabbeke M, Sebban C, Le Cesne A, Judson I, Tredan O, Verweij J, Biron P, Labidi I, Guastalla JP, Bachelot T, Perol D, Chabaud S, Hogendoorn PC, Cassier P, Dufresne A, Blay JY (2009) Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas. Cancer Res 69(13):5383\u20135391. doi: 10.1158\/0008-5472.can-08-3845","journal-title":"Cancer Res"},{"key":"2361_CR26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1475-2891-9-69","volume":"9","author":"D Gupta","year":"2010","unstructured":"Gupta D, Lis CG (2010) Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J 9:69. doi: 10.1186\/1475-2891-9-69","journal-title":"Nutr J"},{"issue":"2","key":"2361_CR27","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1207\/S15327914nc392_8","volume":"39","author":"DC McMillan","year":"2001","unstructured":"McMillan DC, Watson WS, O'Gorman P, Preston T, Scott HR, McArdle CS (2001) Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss. Nutr Cancer 39(2):210\u2013213. doi: 10.1207\/S15327914nc392_8","journal-title":"Nutr Cancer"},{"issue":"9255","key":"2361_CR28","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","volume":"357","author":"F Balkwill","year":"2001","unstructured":"Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357(9255):539\u2013545. doi: 10.1016\/s0140-6736(00)04046-0","journal-title":"Lancet"},{"issue":"2","key":"2361_CR29","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/sj.onc.1204076","volume":"20","author":"SH Jee","year":"2001","unstructured":"Jee SH, Shen SC, Chiu HC, Tsai WL, Kuo ML (2001) Overexpression of interleukin-6 in human basal cell carcinoma cell lines increases anti-apoptotic activity and tumorigenic potency. Oncogene 20(2):198\u2013208. doi: 10.1038\/sj.onc.1204076","journal-title":"Oncogene"},{"issue":"24","key":"2361_CR30","doi-asserted-by":"crossref","first-page":"7492","DOI":"10.1158\/1078-0432.CCR-06-0023","volume":"12","author":"KA Charles","year":"2006","unstructured":"Charles KA, Rivory LP, Brown SL, Liddle C, Clarke SJ, Robertson GR (2006) Transcriptional repression of hepatic cytochrome P450 3A4 gene in the presence of cancer. Clin Cancer Res 12(24):7492\u20137497. doi: 10.1158\/1078-0432.ccr-06-0023","journal-title":"Clin Cancer Res"},{"issue":"3","key":"2361_CR31","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/sj.bjc.6600448","volume":"87","author":"LP Rivory","year":"2002","unstructured":"Rivory LP, Slaviero KA, Clarke SJ (2002) Hepatic cytochrome P450 3A drug metabolism is reduced in cancer patients who have an acute-phase response. Br J Cancer 87(3):277\u2013280. doi: 10.1038\/sj.bjc.6600448","journal-title":"Br J Cancer"},{"key":"2361_CR32","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/(SICI)1097-0215(1998)78:11+<48::AID-IJC14>3.0.CO;2-3","volume":"11","author":"DJ Murry","year":"1998","unstructured":"Murry DJ, Riva L, Poplack DG (1998) Impact of nutrition on pharmacokinetics of anti-neoplastic agents. Int J Cancer Suppl 11:48\u201351","journal-title":"Int J Cancer Suppl"},{"key":"2361_CR33","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1471-2407-11-64","volume":"11","author":"J Kitayama","year":"2011","unstructured":"Kitayama J, Yasuda K, Kawai K, Sunami E, Nagawa H (2011) Circulating lymphocyte is an important determinant of the effectiveness of preoperative radiotherapy in advanced rectal cancer. BMC Cancer 11:64. doi: 10.1186\/1471-2407-11-64","journal-title":"BMC Cancer"},{"issue":"5","key":"2361_CR34","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hed.23357","volume":"36","author":"G Li","year":"2014","unstructured":"Li G, Gao J, Liu ZG, Tao YL, Xu BQ, Tu ZW, Zhang XP, Zeng MS, Xia YF (2014) Influence of pretreatment ideal body weight percentile and albumin on prognosis of nasopharyngeal carcinoma: long-term outcomes of 512 patients from a single institution. Head Neck 36(5):660\u2013666. doi: 10.1002\/hed.23357","journal-title":"Head Neck"},{"issue":"2","key":"2361_CR35","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s12253-010-9306-2","volume":"17","author":"L Gergely","year":"2011","unstructured":"Gergely L, Vancsa A, Miltenyi Z, Simon Z, Barath S, Illes A (2011) Pretreatment T lymphocyte numbers are contributing to the prognostic significance of absolute lymphocyte numbers in B-cell non-Hodgkins lymphomas. Pathol Oncol Res 17(2):249\u2013255. doi: 10.1007\/s12253-010-9306-2","journal-title":"Pathol Oncol Res"},{"issue":"12","key":"2361_CR36","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.1158\/1078-0432.CCR-11-0264","volume":"17","author":"BE Wahlin","year":"2011","unstructured":"Wahlin BE, Sundstrom C, Holte H, Hagberg H, Erlanson M, Nilsson-Ehle H, Linden O, Nordstrom M, Ostenstad B, Geisler CH, Brown Pde N, Lehtinen T, Maisenholder M, Tierens AM, Sander B, Christensson B, Kimby E (2011) T cells in tumors and blood predict outcome in follicular lymphoma treated with rituximab. Clin Cancer Res 17(12):4136\u20134144. doi: 10.1158\/1078-0432.ccr-11-0264","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2361_CR37","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3109\/10428190903308015","volume":"51","author":"D Morales","year":"2010","unstructured":"Morales D, Beltran B, De Mendoza FH, Riva L, Yabar A, Qui\u00f1ones P, Butera JN, Castillo J (2010) Epstein-Barr virus as a prognostic factor in de novo nodal diffuse large B-cell lymphoma. Leuk Lymphoma 51(1):66\u201372, 1042-8194","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"2361_CR38","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/ajh.23422","volume":"88","author":"YJ Li","year":"2013","unstructured":"Li YJ, Jiang WQ, Huang JJ, Xia ZJ, Huang HQ, Li ZM (2013) The Glasgow Prognostic Score (GPS) as a novel and significant predictor of extranodal natural killer\/T-cell lymphoma, nasal type. Am J Hematol 88(5):394\u2013399. doi: 10.1002\/ajh.23422","journal-title":"Am J Hematol"},{"key":"2361_CR39","doi-asserted-by":"crossref","unstructured":"Guo CC, Huang Y, Xiao J, Zhang YJ, Tian Y, Wang SS, Cao YB, Fu X, Zhai LZ, Lin TY (2008) Prognostic impact of circulating Epstein-Barr virus (EBV) DNA concentration and EBV serology in T-cell non-Hodgkin's lymphoma (T-NHL). In: ASCO, 26, 15S, p 8556","DOI":"10.1200\/jco.2008.26.15_suppl.8556"},{"issue":"15","key":"2361_CR40","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1158\/1078-0432.CCR-12-1064","volume":"18","author":"Y Ito","year":"2012","unstructured":"Ito Y, Kimura H, Maeda Y, Hashimoto C, Ishida F, Izutsu K, Fukushima N, Isobe Y, Takizawa J, Hasegawa Y, Kobayashi H, Okamura S, Kobayashi H, Yamaguchi M, Suzumiya J, Hyo R, Nakamura S, Kawa K, Oshimi K, Suzuki R (2012) Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK\/T-cell lymphoma, nasal type. Clin Cancer Res 18(15):4183\u20134190. doi: 10.1158\/1078-0432.ccr-12-1064","journal-title":"Clin Cancer Res"},{"issue":"4","key":"2361_CR41","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/lary.24371","volume":"124","author":"A Vazquez","year":"2014","unstructured":"Vazquez A, Khan MN, Blake DM, Sanghvi S, Baredes S, Eloy JA (2014) Extranodal natural killer\/T-Cell lymphoma: a population-based comparison of sinonasal and extranasal disease. Laryngoscope 124(4):888\u2013895. doi: 10.1002\/lary.24371","journal-title":"Laryngoscope"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-015-2361-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-015-2361-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-015-2361-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T11:14:02Z","timestamp":1566558842000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-015-2361-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,15]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["2361"],"URL":"https:\/\/doi.org\/10.1007\/s00277-015-2361-8","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,15]]}}}